Overview

Brief Intervention to Reduce Fear of Public Speaking

Status:
Terminated
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
The study will test the efficacy of propranolol or placebo, administered after retrieval of a previously acquired public speaking fear, in reducing fear and avoidance of public speaking.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Propranolol